[The Unique Challenges of Treating and Caring for Older Adult Patients With Cancer].

医学 癌症 老年学 重症监护医学 内科学
作者
Yuanyuan Fang
出处
期刊:PubMed 卷期号:71 (6): 4-7
标识
DOI:10.6224/jn.202412_71(6).01
摘要

In older age, tissue degeneration, decreased cellular competition, and the declining efficiency of clearance mechanisms lead to higher rates of survival and accumulation for cells with adaptive mutations, which increase the risk of cancer cell development (Laconi et al., 2020). Thus, age is a significant risk factor for cancer. It is projected that by 2050, the global population aged 60 and above will rise to 2.1 billion, with those aged 80 and above expected to reach 426 million (World Health Organization, 2024). Taiwan, which became an aging society in 2018, is expected to be a nation in which older adults constitute 46.5% of the total population by 2070 (National Development Council, 2024). As the older adult population increases, the number of patients with cancer will also almost certainly continue to rise. Older adults respond differently to traditional cancer treatments than younger individuals, often experiencing declines in physical function, frailty, and cognitive impairment (Extermann, 2000). Moreover, older adult patients frequently have multiple chronic diseases (e.g., cardiovascular disease, diabetes, pulmonary, renal, liver diseases) that increase the complexity and risks associated with cancer treatment (Dale et al., 2012). They may also use over-the-counter medications or herbal supplements in addition to prescription drugs (Maggiore et al., 2010), which raises the risk of treatment toxicity and complications, presenting challenges for treatment decision-making. According to a survey by the National Cancer Institute, only 32% of patients with cancer participating in clinical trials were over 65 years old (Murthy et al., 2004). This may relate to the common exclusion of patients with comorbidities, physician attitudes, and/or the lower willingness of older adult patients to participate (Lewis et al., 2003). Thus, existing data may be insufficient to support the development of optimal treatment plans for older adult patients with cancer (Dale et al., 2012; Extermann, 2000). Age discrimination may lead to undertreatment or overtreatment, affecting patients' functional status and quality of life (Extermann, 2000; Hamaker et al., 2022). Currently, most oncology research relies on either the Eastern Cooperative Oncology Group performance status scale or Karnofsky Performance Scale to assess health status. However, neither adequately differentiates for the characteristics of older adult patients (Pal et al., 2010). In assessing quality of life in patients with cancer, the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire or Medical Outcomes Study 36-item Short Form Health Survey is commonly used. However, these tools lack targeted assessments for cognitive function, activities of daily living, and autonomy (such as cooking, shopping, making phone calls, and managing finances), which are issues of particular concern in older adult patients (Terret et al., 2011). The American Society of Clinical Oncology recommends that older adult cancer care should include geriatric assessments (GAs) of key elements such as functional status, mental health, cognitive ability, nutritional status, chemotherapy toxicity risks, life expectancy, comorbidities, fall history, and social support to provide critical reference data for treatment planning (Chapman et al., 2021; Dale et al., 2023; Hamaker et al., 2022). However, a randomized controlled trial showed that GAs do not significantly improve physical function or quality of life for older adult patients with cancer, suggesting the benefits of these assessments remain unclear (Portielje & van den Bos, 2024). Nevertheless, other studies have shown that GAs significantly reduce chemotherapy toxicity and improve satisfaction among patients and their families (Dale et al., 2023). Despite these recommendations, knowledge of geriatric oncology has not been widely integrated into medical training, and GAs have not been incorporated into clinical care processes (Chapman et al., 2021; Diaz et al., 2024), highlighting a global healthcare system lacking the expertise and skills necessary to provide appropriate targeted care for older adult patients with cancer. Given the increasing importance of geriatric cancer care, this column provides an in-depth exploration of the care needs of older adult patients with cancer, treatment decision-making, cognitive impairment issues, and the burdens faced by family caregivers. The four articles within are geared toward enhancing the knowledge and skills of nursing professionals in geriatric oncology care and, ultimately, improving the quality of care provided to older adult patients with cancer.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
慕青应助熠熠采纳,获得10
刚刚
Yoki发布了新的文献求助30
1秒前
zhanyusun完成签到,获得积分20
1秒前
bryce发布了新的文献求助10
1秒前
aa发布了新的文献求助10
2秒前
2秒前
cuberblue发布了新的文献求助10
2秒前
情怀应助easymoney采纳,获得10
3秒前
起朱楼应助阿辉采纳,获得20
3秒前
夏天不回来完成签到,获得积分10
3秒前
乐乐应助lai采纳,获得10
3秒前
4秒前
4秒前
小海绵完成签到,获得积分10
5秒前
5秒前
perway发布了新的文献求助10
6秒前
蘇尼Ai发布了新的文献求助10
6秒前
yyy发布了新的文献求助10
6秒前
7秒前
7秒前
7秒前
bryce完成签到,获得积分10
7秒前
8秒前
fox完成签到 ,获得积分10
8秒前
JamesPei应助大萌采纳,获得10
8秒前
singber完成签到,获得积分10
8秒前
9秒前
lalala发布了新的文献求助10
9秒前
luoluo完成签到,获得积分10
9秒前
10秒前
10秒前
11秒前
复活发布了新的文献求助10
11秒前
明亮的小蘑菇应助LIO采纳,获得30
11秒前
11秒前
英俊的铭应助猪猪hero采纳,获得10
11秒前
11秒前
木子西发布了新的文献求助10
12秒前
12秒前
13秒前
高分求助中
The Mother of All Tableaux Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 2400
Ophthalmic Equipment Market by Devices(surgical: vitreorentinal,IOLs,OVDs,contact lens,RGP lens,backflush,diagnostic&monitoring:OCT,actorefractor,keratometer,tonometer,ophthalmoscpe,OVD), End User,Buying Criteria-Global Forecast to2029 2000
Optimal Transport: A Comprehensive Introduction to Modeling, Analysis, Simulation, Applications 800
Official Methods of Analysis of AOAC INTERNATIONAL 600
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 588
T/CIET 1202-2025 可吸收再生氧化纤维素止血材料 500
Comparison of adverse drug reactions of heparin and its derivates in the European Economic Area based on data from EudraVigilance between 2017 and 2021 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3952008
求助须知:如何正确求助?哪些是违规求助? 3497414
关于积分的说明 11087298
捐赠科研通 3228031
什么是DOI,文献DOI怎么找? 1784626
邀请新用户注册赠送积分活动 868824
科研通“疑难数据库(出版商)”最低求助积分说明 801198